Common platform for macromolecular crystallography at European synchrotrons
MXcuBE Meeting from 1st - 2nd of December 2015 at Alba, Barcelona. The meetings make sure that the devenlopment of MXcuBE3 closly fits to the needs of the users.
Photo: Jordi Juanhuix/ALBA
Researchers use high-intensity X-ray light from synchrotron radiation sources to decipher the structures of biological molecules and thus the blueprints of life. A cooperation agreement has been effective since 2012 to establish common software standards at several European sources. Its aim: The eight synchrotrons involved want to create user-friendly, standardised conditions at the 30 experimental stations for macromolecular crystallography, which will greatly facilitate the work of research groups. In the new project “MXCuBE3”, the existing software platform is being adapted to include the latest developments in technology.
Many of the beamlines for macromolecular crystallography have been extensively modernised at various synchrotrons over the past few years. With new equipment, such as the latest high-resolution detectors, this opens up all new possibilities for experimentation. The common software platform MXCuBE2 now has to be adapted as well to keep up with this trend. The Curatorship has accordingly called for a new, overhauled version to be developed. The software solution MXCuBE3 will allow users to control their experiments via web applications. The upgrade will also guarantee MXCuBE3 will continue to run on computers with future operating systems, and will improve the connection to the sample database ISPyB.
Involved in the cooperation are the Helmholtz-Zentrum Berlin, the ESRF, the European Molecular Biology Laboratory, Global Phasing Limited, MAX-VI-Lab in Sweden, SOLEIL in France, ALBA in Spain and DESY.
Read up on this in more detail in the ESRF magazine
- Protein crystallography at BESSY II: faster, better and more and more automaticMany diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with Manfred Weiss, head of the research group for macromolecular crystallography.
- Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. UhlAlexander R. Uhl, UBC Okanagan School of Engineering in Kelowna, Canada, aims to develop with Roel van de Krol from the HZB Institute for Solar Fuels an efficient and inexpensive photoelectrolyser for producing hydrogen using sunlight. His stay is being funded by the Alexander von Humboldt Foundation.
- 5000th protein structure at BESSY II: Starting point for a COVID drugMany proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.